| Catalog Number |
D128208 |
| Medical Device Problem Code |
Obstruction of Flow (2423)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/26/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that it was noticed that the pentaray nav was not flushing at all before readvancing the pentaray nav back into the body for a post-map.The pentaray nav was flushed but the issue persisted.The pentaray nav was replaced and the procedure continued with no further issues.The caller stated that the faulty pentaray nav was brand new.There was no patient consequence.
|
| |
|
Additional Manufacturer Narrative
|
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's ref.# (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
It was reported that it was noticed that the pentaray nav was not flushing at all before readvancing the pentaray nav back into the body for a post-map.Device investigation details: an analysis of the product could not be performed since a physical sample was not received for evaluation.However, if the product is received at a later date, the investigation will be updated as applicable.A manufacturing record evaluation was performed for the finished device number lot 31700005l and no internal action related to the complaint was found during the review.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
| |
|
Search Alerts/Recalls
|